Vector Science & Therapeutics Grants Stock Options to Directors

Vector Science & Therapeutics (TSXV: PAIN) announced the granting of stock options to certain directors as part of its growth strategy. The 206,610 options have an exercise price of C$1.69 and vest throughout 2026.

By Vector Sciences & Therapeutics · PR Newswire · June 2, 2026, 11:45 UTC

Topics: board of directors stock options TSX Venture Exchange

Read the full article at PR Newswire

More World news

Pomerantz Law Firm Investigates Boston Scientific Following Q3 Earnings Miss and Guidance Downgrade PR Newswire · November 12, 2026, 15:35 UTC
Jensen Huang Concludes 33-Year Tenure as CEO of Nvidia Seeking Alpha · November 12, 2026, 15:29 UTC
Metalla Royalty & Streaming Reports Q3 Revenue Growth and Increased Adjusted EBITDA Seeking Alpha · November 12, 2026, 15:26 UTC
Fed Governor Michael Barr Warns AI Market Concentration Could Drive Income Inequality Seeking Alpha · November 12, 2026, 15:27 UTC
Jefferies Upgrades Pattern Group (PTRN) Following Strong Brand Acquisition Performance Seeking Alpha · November 12, 2026, 15:27 UTC
Pomerantz Law Firm Investigates Six Flags Entertainment Corporation Following Fatal Roller Coaster Accident PR Newswire · November 12, 2026, 15:30 UTC
SpaceX Partners with Qualcomm to Launch Starlink Mobile Cellular Service Motley Fool · November 12, 2026, 15:21 UTC
Blast Resources Appoints Andy Yackulic as CEO to Lead Uranium Exploration PR Newswire · November 12, 2026, 15:26 UTC
FMC Corporation Shares Decline 13% in Thursday Trading Seeking Alpha · November 12, 2026, 15:22 UTC
U.S. Stock Indices Decline Following Nvidia CEO Jensen Huang's Resignation Seeking Alpha · November 12, 2026, 15:23 UTC